Living in the matrix: assembly and control of Vibrio cholerae biofilms
Jennifer K. Teschler,David Zamorano-Sánchez,Andrew S. Utada,Christopher J. A. Warner,Gerard C. L. Wong,Roger G. Linington,Fitnat H. Yildiz
DOI: https://doi.org/10.1038/nrmicro3433
IF: 88.1
2015-04-16
Nature Reviews Microbiology
Abstract:Key PointsBiofilms of Vibrio cholerae, the causative agent of cholera, have an important role during the aquatic and intestinal phases of the bacterial life cycle, conferring greater resistance to environmental stresses and increasing infectivity.V. cholerae biofilm formation is a multistep process that begins with initial attachment via the bacterial mannose-sensitive haemagglutinin (MSHA) pili. The key components of a V. cholerae biofilm are secreted by the cell at various times during biofilm formation and include Vibrio polysaccharide (VPS), the biofilm proteins rugosity and biofilm structure modulator A (RbmA), Bap1 and RbmC, and extracellular DNA, all of which are critical for the formation of mature biofilms.Biofilm formation in V. cholerae is controlled by an integrated network of transcriptional regulators. The major transcriptional activators include VpsR, VpsT and AphA, and major transcriptional repressors include HapR and H-NS; alternative RNA polymerase sigma factors, regulatory small RNAs and signalling molecules also function as regulators of this complex process.Nucleotide-based signals play an important part in controlling biofilm formation and include cyclic di-GMP (c-di-GMP), which positively regulates biofilm formation and negatively regulates motility to influence the planktonic-to-biofilm transition. Additionally, cyclic AMP represses biofilm formation, and guanosine tetraphosphate and guanosine pentaphosphate (collectively called (p)ppGpp) enhance biofilm formation.V. cholerae biofilm formation is influenced by a number of fluctuating environmental factors, including nutritional status, shifts in salinity and osmolarity, phosphate limitation, the presence of polyamines, variations in calcium levels, and exposure to indole and bile. The ability of V. cholerae to activate or repress biofilm formation in response to external signals probably contributes to the environmental survival and persistence of the bacterium and demonstrates the complexity of the biofilm regulation programme.New small-molecule therapeutics have emerged that target and disrupt V. cholerae biofilm formation. Such therapeutics include quorum sensing inhibitors, disruptors of c-di-GMP signalling and compounds with unknown molecular targets. Whole-cell phenotypic imaging coupled with cellular-viability measurements have been used to differentiate bactericidal agents and compounds that selectively disrupt biofilm formation without affecting cell survival. These studies have led to the discovery of several compounds that show promise for biofilm inhibition and for the treatment of cholera.
microbiology